DANAYE PEREZ: Open Payments
NPI 1649956814 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 59 payments from 19 companies in 2025. Trend: 2023 $61 · 2024 $1,249 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $117 |
| Ardelyx, Inc. | 3 | $71 |
| Novo Nordisk Inc | 4 | $67 |
| Lilly USA, LLC | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 4 | $42 |
Products named: CAPLYTA, Kerendia, VRAYLAR, IBSRELA, MOUNJARO, JARDIANCE, UBRELVY, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
